Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males and females of childbearing potential (willing to use an acceptable method of contraception), or females of non-childbearing potential (i.e., post-menopausal or surgically sterile)
Diagnosis of type 2 diabetes treated with metformin monotherapy on a stable regimen for at least 2 months
Body Mass Index (BMI) of 18 to 40 kg/m2
Fasting glucose in the range of 100-250 mg/dL
Hemoglobin A1c (HbA1c) in the range of 6.5% -9.5%
You may not be if
Clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
Any significant acute or chronic medical illness other than stable and well controlled hypertension, microalbuminuria, dyslipidemia, or depression
Past history of diabetic ketoacidosis and/or C-peptide \< 1.0 ng/mL, hyperosmolar nonketotic syndrome, lactic acidosis, or recurrent hypoglycemia
Any major surgery within 4 weeks of study drug administration
Any gastrointestinal surgery that could impact upon the absorption of study drug
Smoking more than 10 cigarettes per day
Recent drug or alcohol abuse
Women who are pregnant or breastfeeding
Positive urine screen for drugs of abuse
Positive blood screen for hepatitis C antibody, hepatitis B surface antigen, or HIV-1, -2 antibody
Clareo Health | Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
